192 related articles for article (PubMed ID: 20093514)
21. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.
Jia Z; Zhang J; Wei D; Wang L; Yuan P; Le X; Li Q; Yao J; Xie K
Cancer Res; 2007 May; 67(10):4878-85. PubMed ID: 17510417
[TBL] [Abstract][Full Text] [Related]
22. Monitoring of bevacizumab-induced antiangiogenic treatment effects by "steady state" ultrasmall superparamagnetic iron oxide particles magnetic resonance imaging using robust multiecho ΔR2* relaxometry.
Ring J; Persigehl T; Remmele S; Heindel W; Dahnke H; Bremer C
Invest Radiol; 2011 May; 46(5):326-30. PubMed ID: 21358548
[TBL] [Abstract][Full Text] [Related]
23. Effect of vascular endothelial growth factor inhibition on endometrial implant development in a murine model of endometriosis.
Ricci AG; Olivares CN; Bilotas MA; Meresman GF; Barañao RI
Reprod Sci; 2011 Jul; 18(7):614-22. PubMed ID: 21266664
[TBL] [Abstract][Full Text] [Related]
24. Effect of bevacizumab on angiogenesis and growth of canine osteosarcoma cells xenografted in athymic mice.
Scharf VF; Farese JP; Coomer AR; Milner RJ; Taylor DP; Salute ME; Chang MN; Neal D; Siemann DW
Am J Vet Res; 2013 May; 74(5):771-8. PubMed ID: 23627391
[TBL] [Abstract][Full Text] [Related]
25. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
[TBL] [Abstract][Full Text] [Related]
26. Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.
Wang H; Hristov D; Qin J; Tian L; Willmann JK
Radiology; 2015 Nov; 277(2):424-34. PubMed ID: 26020439
[TBL] [Abstract][Full Text] [Related]
27. Contrast enhanced ultrasonography (CEUS) in the characterization of tumor microcirculation. Validation of the procedure in the animal experimental model.
Badea AF; Tamas-Szora A; Clichici S; Socaciu M; Tăbăran AF; Băciut G; Cătoi C; Mureşan A; Buruian M; Badea R
Med Ultrason; 2013 Jun; 15(2):85-94. PubMed ID: 23702496
[TBL] [Abstract][Full Text] [Related]
28. Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.
Niermann KJ; Fleischer AC; Huamani J; Yankeelov TE; Kim DW; Wilson WD; Hallahan DE
J Ultrasound Med; 2007 Jun; 26(6):749-56. PubMed ID: 17526606
[TBL] [Abstract][Full Text] [Related]
29. Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.
Leguerney I; Lassau N; Koscielny S; Rodrigues M; Massard C; Rouffiac V; Benatsou B; Thalmensi J; Bawa O; Opolon P; Peronneau P; Roche A
Invest New Drugs; 2012 Feb; 30(1):144-56. PubMed ID: 20924644
[TBL] [Abstract][Full Text] [Related]
30. Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer model.
Mabuchi S; Terai Y; Morishige K; Tanabe-Kimura A; Sasaki H; Kanemura M; Tsunetoh S; Tanaka Y; Sakata M; Burger RA; Kimura T; Ohmichi M
Clin Cancer Res; 2008 Dec; 14(23):7781-9. PubMed ID: 19047105
[TBL] [Abstract][Full Text] [Related]
31. A new algorithm for a better characterization and timing of the anti-VEGF vascular effect named "normalization".
El Alaoui-Lasmaili K; Djermoune EH; Tylcz JB; Meng D; Plénat F; Thomas N; Faivre B
Angiogenesis; 2017 Feb; 20(1):149-162. PubMed ID: 27942994
[TBL] [Abstract][Full Text] [Related]
32. Contrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment.
Zhou JH; Zheng W; Cao LH; Liu M; Luo RZ; Han F; Wu PH; Li AH
Eur J Radiol; 2012 Jun; 81(6):1360-5. PubMed ID: 21345633
[TBL] [Abstract][Full Text] [Related]
33. [Value of ultrasound-targeted vascular endothelial growth factor receptor-2 in non-invasive monitoring of anti-angiogenic response in nude mice with subcutaneous xenograft model].
Wang L; Lu YH; Wang TY
Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):856-860. PubMed ID: 33113627
[No Abstract] [Full Text] [Related]
34. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice.
Shen ZY; Shen E; Zhang JZ; Bai WK; Wang Y; Yang SL; Nan SL; Lin YD; Li Y; Hu B
Oncol Rep; 2013 Aug; 30(2):842-50. PubMed ID: 23707983
[TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice.
Hurwitz SJ; Zhang H; Yun S; Batuwangala TD; Steward M; Holmes SD; Rycroft D; Pan L; Tighiouart M; Shin HJ; Koenig L; Wang Y; Chen ZG; Shin DM
Cancer Chemother Pharmacol; 2012 Mar; 69(3):577-90. PubMed ID: 21913035
[TBL] [Abstract][Full Text] [Related]
36. Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.
Dings RP; Loren M; Heun H; McNiel E; Griffioen AW; Mayo KH; Griffin RJ
Clin Cancer Res; 2007 Jun; 13(11):3395-402. PubMed ID: 17545548
[TBL] [Abstract][Full Text] [Related]
37. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.
Turetschek K; Preda A; Novikov V; Brasch RC; Weinmann HJ; Wunderbaldinger P; Roberts TP
J Magn Reson Imaging; 2004 Jul; 20(1):138-44. PubMed ID: 15221819
[TBL] [Abstract][Full Text] [Related]
38. [Effect of vascular endothelial growth factor antibody Avastin on angiogenesis of human gastric cancer growing orthotopically in nude mice].
Wang N; Wang B; Wang YJ
Ai Zheng; 2006 Sep; 25(9):1076-81. PubMed ID: 16965645
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced US quantitatively detects changes of tumor perfusion in a murine breast cancer model during adriamycin chemotherapy.
Wang JW; Cao LH; Han F; Zheng W; Chen Y; Li AH; Zhou JH
Acta Radiol; 2013 Oct; 54(8):882-8. PubMed ID: 23761553
[TBL] [Abstract][Full Text] [Related]
40. Anti-vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors.
Wong HK; Lahdenranta J; Kamoun WS; Chan AW; McClatchey AI; Plotkin SR; Jain RK; di Tomaso E
Cancer Res; 2010 May; 70(9):3483-93. PubMed ID: 20406973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
